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Background: We sought to identify risk factors associated with mortality following surgery 
for peripheral arterial disease (PAD).
Methods: We evaluated the association between levels of control of atherosclerotic risk factors 
and time to mortality following either lower extremity bypass surgery or lower extremity 
  amputation using Cox proportional hazards regression.
Results: Among 796 patients with PAD (defined by an ankle-brachial index [ABI]  0.9), 230 
(28.9%) underwent an operation for PAD (136, lower-extremity bypasses; 111, lower-extremity 
amputations). Participants were followed for up to six years after their diagnosis of PAD. A total 
of 107 (46.5% of the 230) died during the period of follow-up. Factors associated with mortality 
following lower extremity bypass surgery included age 70 years and older hazard ratio [HR] 
1.88; 95% confidence interval [CI]: 1.01–3.51) and of African American race (HR 1.94; 95% 
CI: 1.04–3.62). Renal insufficiency was significantly associated with mortality following lower 
extremity amputation (HR 2.19; 95% CI: 1.16–4.13).
Conclusion: Our data provide information on preoperative risk variables to consider when 
assessing long-term mortality in persons with PAD who are undergoing surgery for PAD.
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Introduction
Peripheral arterial disease (PAD) affects 8–12 million Americans.1,2 The primary goal 
in managing PAD is to reduce both cardiovascular events, such as myocardial infarction 
or stroke, and limb events, such as progressive ischemia that requires lower-extremity 
surgical bypass or amputation.1,3 Leg amputation is associated with ongoing impairment 
of functional status and quality-of-life.4 Although less devastating than lower extrem-
ity amputation, lower-extremity bypass surgery is associated with 30-day mortality 
from 2% to 8% and five-year graft failure rates from 50% to 90% with higher rates of 
failure for persons with critical limb ischemia versus claudication.5 In addition, PAD 
patients who undergo lower extremity bypass surgery have a 20% risk of amputation 
within 5 years.3,6
Aside from surgical therapy, risk factor modification is an important treatment 
modality for PAD. Risk factors for PAD include smoking, diabetes mellitus, hyper-
tension, and dyslipidemia.7–9 Treatment of these risk factors should, optimally, reduce 
both systemic outcomes (such as myocardial infarction and stroke) and surgical limb 
events. For patients who require limb surgery, the risk for postoperative survival 
should be optimized. The focus of this work was to determine risk factors for mortality 
following lower extremity revascularization or amputation for PAD.Vascular Health and Risk Management 2010:6 288
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Methods
Study population
Consecutive patients evaluated at the Michael E DeBakey 
Veterans Affairs Medical Center (MEDVAMC) noninvasive 
vascular laboratory from 1995 to 1998 with a diagnosis of 
PAD based on an ankle-brachial index (ABI) of 0.90 were 
included in this study. Patients who had undergone a prior 
lower extremity vascular surgical revascularization procedure 
or a major amputation were excluded. The Baylor College of 
Medicine Institutional Review Board approved this study.
Detailed information for the methods of this retrospective 
cohort study has been previously published.10 We obtained 
information on first limb event (bypass surgery or amputa-
tion) and mortality through the end of the observation period 
(December 31, 2001). Our retrospective cohort included 
patient record abstractions starting as early as January 1, 
1992 and ending with medical records dated at the time 
of the surgical limb event, death, or December 31, 2001, 
whichever occurred first.
Data source
We used medical records from the Veterans Integrated 
Systems Technology Architecture (VISTA) to identify our 
cohort and identified outcomes.
Primary outcome
The primary outcome was all-cause mortality following 
lower extremity bypass surgery or lower extremity amputa-
tion as individual surgical events. Lower extremity bypass 
surgeries included aortoiliac or aortobifemoral, femoropop-
liteal bypass, above or below the knee, and femorotibial 
vascular bypass. Lower extremity amputations included 
below-the-knee and above-the-knee major procedures 
(transmetatarsal or toe amputations were not included). 
Patients who had undergone lower extremity bypass 
surgery followed by amputation of the same or contralateral 
extremity were considered in both analyses. This study did 
not evaluate mortality following endovascular procedures 
as these procedures were not performed in large numbers 
until after 2001.
Independent variables
In addition to standard patient demographic measures, poten-
tial correlates of mortality included levels of actual risk factor 
control (separately for smoking cessation, glycemic control, 
blood pressure control, and lipid control). We also tracked 
cohort members’ exposure to pharmacological therapy for 
each of the four risk factors as well as antiplatelet therapy.
Data collection
Trained nurse chart abstractors blinded to the study purpose 
completed the chart reviews using standardized data extrac-
tion forms developed by study investigators. The nurses cap-
tured information on the patient’s age, dates of clinic visits, 
reason for clinic visits, symptoms, physical examination 
findings (eg, vital signs), diagnoses, and modifiable risk fac-
tors. Mortality and additional study data were abstracted from 
the facility electronic medical record and from the national 
Veterans Affairs administrative files including the Benefi-
ciary Identification and Records Locator Subsystem (BIRLS) 
Mortality File and the patient treatment file (PTF).
Risk factor control
We determined effective control of a risk factor based on 
documentation from charted vital signs or extracted labora-
tory data. We defined control of each risk factor according to 
national guidelines, including those of the National Choles-
terol Education Panel; Joint National Committee on Detection, 
Evaluation, and Management of Hypertension; American 
Diabetes Association; and American Cancer Society.11–15
Statistical analysis
We implemented a bootstrap model selection procedure, as 
discussed by Austin and Tu,16 to develop predictive models 
for survival after bypass and for survival after amputation. 
To develop each model we used 250 replications of the boot-
strapping process described forthwith. Within each replication 
we created a simple bootstrapped version of the sample and 
implemented a stepwise model selection procedure to con-
struct a Cox proportional hazards survival model using the 
covariates, described in detail below, as potential predictors. 
The model selection procedure used P-value based selection 
and retention criteria of 0.20 and 0.25, respectively, for the 
significance tests of individual predictors. Such liberal criteria 
are often chosen to reduce biased estimation of regression 
parameters with model selection procedures, as discussed 
by Greenland,17 Mickey and Greenland.18 Those predictors 
selected in more than one-half of these bootstrapped models 
were included in the subsequent Cox proportional hazards 
regression model fit to the original sample.
The covariates considered as potential predictors included 
race, index ABI severity, history of coronary artery disease 
(CAD), most recent serum creatinine prior to surgery, use of 
ace inhibitors, beta-blockers, calcium channel blockers, and 
PAD medications within three months of surgery. The model 
development process also considered smoking, hypertension, 
cholesterol, and diabetes risk factors together with measures Vascular Health and Risk Management 2010:6 289
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of the control of these risk factors and use of medications 
to treat these risk factors within the three months prior to 
surgery as potential predictors. These latter medications 
included diuretics and other antihypertensive medications, 
diabetes medications, lipid lowering medications, and smok-
ing cessation medications.
Measures of risk factor control were constructed as the 
proportion of risk assessments (ie, blood pressure, lipid 
panel, blood glucose) prior to surgery indicating the risk 
factor was controlled. For a large proportion of individuals, 
up to 33% for some risk factors, there was no risk assessment 
performed or documented in their records. For these individu-
als, we imputed a proportion of control using results of an 
overdispersed logistic regression model, fit using the data 
for those with assessments, for the number of assessments 
indicating control over the number of assessments using the 
above covariates as predictors.
Results
We identified 796 veterans with PAD among whom 230 patients 
underwent lower extremity bypass surgery or lower extrem-
ity amputation. The following characteristics describe those 
veterans who were treated with lower extremity bypass sur-
gery or underwent a lower extremity amputation (Table 1). 
The mean age of veterans who experienced an adverse limb 
event was 64.1 ± 10.1 years; 99% were men; 83 (36.1%) 
were African American; 15 (6.5%) were Latino; and 132 
(57.4%) were white or of unknown race. Individuals were 
classified according to the tertiles of index PAD severity: 
mild (0.70–0.89), moderate (0.41–0.69), and severe (0.40). 
Table 1 Baseline characteristics of the cohort
Variable  Total cohort (N = 230)  Patients undergoing  
bypass (N = 136)
Patients undergoing 
  amputation (N = 111)
Age
Mean age (SD) 64.1 (10.1) 62.5 (9.9) 66.6 (9.9)
Age  60 years 66 (28.7%) 44 (32.4%) 24 (21.6%)
Age 60–70 years 94 (40.9%) 60 (44.1%) 42 (37.8%)
Age 70 years and older 70 (30.4%) 32 (23.5%) 45 (40.5%)
Sex
Male 228 (99.1%) 134 (98.5%) 111 (100%)
Race/Ethnicity
African American 83 (36.1%) 41 (30.2%) 49 (44.1%)
Latino 15 (6.5%) 4 (2.9%) 12 (10.8%)
White/Other/Unknown 132 (57.4%) 91 (66.9%) 50 (45.1%)
ABI severity
Mean ABI (SD) 0.47 (0.16) 0.47 (0.14) 0.47 (0.18)
Critical  0.40 66 (28.7%) 37 (27.2%) 38 (34.2%)
Moderate 0.41 to 0.69 147 (63.9%) 92 (67.7%) 63 (56.8%)
Mild 0.70–0.89 17 (7.4%) 7 (5.1%) 10 (9.0%)
Creatinine levels
None 33 (14.4%) 21 (15.4%) 14 (12.6%)
1.0 70 (30.4%) 43 (31.6%) 36 (32.4%)
1.0–1.5 88 (38.3%) 58 (42.7%) 35 (31.5%)
1.6 or higher 39 (17.0%) 14 (10.3%) 26 (23.4%)
Atherosclerotic risk factors
Diabetes mellitus 148 (64.4%) 70 (51.5%) 88 (79.3%)
Hypertension 181 (78.7%) 102 (75.0%) 90 (81.1%)
Hyperlipidemia 141 (61.3%) 90 (66.2%) 58 (52.3%)
Recent smoking status
  Current smoking 81 (35.2%) 59 (43.4%) 29 (26.1%)
  Nonsmoking 14 (6.1%) 6 (4.4%) 8 (7.2 %)
  Not documented 135 (58.7%) 71 (52.2%) 74 (66.7%)
(Continued)Vascular Health and Risk Management 2010:6 290
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As defined by the index ABI level, the prevalence of critical 
PAD was 28.7%, moderately severe disease was 63.9%, and 
mildly severe disease was 7.4%. As captured any time during 
the observation period, 148 (64.4%) had diabetes mellitus, 
141 (61.3%) had elevated low-density lipoprotein (LDL), 
and 181 (78.7%) had hypertension.
Among those undergoing lower extremity bypass surgeries, 
African Americans comprised 30.2%, Latinos comprised 2.9%, 
and non-Hispanic whites comprised 66.9% of this cohort. In 
contrast, African Americans and Latinos comprised 44.1% and 
10.8%, respectively, of the cohort undergoing lower extremity 
amputations while non-Hispanic whites comprised 45.1%.
The risk factors identified for incorporation in the model 
for mortality following lower extremity bypass surgery were 
African American race hazard ratio [HR] 1.94; 95% confi-
dence interval [CI] 1.04–3.62), age 70 years or older (HR 
1.88, 95% confidence interval [CI]: 1.01–3.51), and index ABI 
(HR 0.12; 95% CI: 0.01–1.09) (Table 2). Figures 1–3 pres-
ent model-based estimated survival curves for survival after 
bypass by age, index ABI, and race/ethnicity. In construct-
ing the survival curve estimates for each figure, the other 
predictors were fixed at the most prevalent or median level.
Risk factors identifed for inclusion in the model for 
mortality following lower extremity amputation included 
index ABI, smoking status, history of CAD, latest serum 
creatinine, and days between index and amputation. While 
the standard regression test results for the significance of 
ABI and smoking are marginally significant at best, the 
model-estimated coefficients for these predictors are gener-
ally consistent with expectations. Interestingly, the model 
suggests that nonassessment of smoking status is associated 
with increased mortality. As illustrated in Table 2, history 
of CAD is associated with increased mortality (HR 1.79; 
95% CI: 1.05–3.05). Similarly, elevated serum creatinine 
is associated with increased mortality with approximate 
doubling of the hazard, relative to a serum creatinine less 
than 1, between 1 and 1.5 (HR 2.12; 95% CI: 1.11–4.03), 
and between 1.5 and 2.0 (HR 2.50, 95% CI: 1.05–5.93). An 
Table 2 Risk factors for mortality following each type of surgery
Variable P value Hazard ratio 95% confidence 
limits
Lower extremity bypass surgery
Index ABI 0.059 0.12 0.01, 1.09
Age 70 years and older 0.048 1.88 1.01, 3.51
African American race/
ethnicity
0.038 1.94 1.04, 3.62
Lower extremity amputation
Index ABI 0.089 1.46 0.90, 2.35
Days between index and 
amputation
0.066 1.001 1.000, 1.002
Recent smoking status#
  Current smoker 0.122 0.58 0.29, 1.16
  Nonsmoker 0.076 0.37 0.12, 1.11
  History of CAD 0.034 1.79 1.05, 3.05
Serum creatinine*
  1.0 to 1.5 0.022 2.19 1.16, 4.13
  1.5 to 2.0 0.038 3.84 1.94, 7.62
  2.0 or greater 0.001 4.51 2.00, 10.17
  Unmeasured 0.068 2.12 0.95, 4.77
Notes: #P-value for overall test for smoking status = 0.089, no assessment of smoking 
status was used as reference.
*P-value for overall test for serum creatinine effects = 0.008, unknown status used 
as reference.
Table 1 (Continued)
Variable  Total cohort (N = 230)  Patients undergoing  
bypass (N = 136)
Patients undergoing 
  amputation (N = 111)
Medication use
ACE inhibitor 38 (16.5%) 20 (14.7%) 19 (17.1%)
Beta blocker 20 (8.7%) 10 (7.4%) 10 (9.0%)
Calcium channel blocker 44 (19.1%) 28 (20.6%) 17 (15.3%)
Diuretic 45 (19.6%) 18 (13.2%) 29 (26.1%)
Antihypertensive medication 98 (42.6%) 50 (36.8%) 50 (45.0%)
Lipid-lowering medication 20 (8.7%) 15 (11.0%) 5 (4.5%)
Diabetes medication 59 (25.6%) 18 (13.2%) 42 (37.8%)
Smoking cessation medication 2 (0.9%) 2 (0.9%) 0 (0.0%)
PAD medication 69 (30.0%) 35 (25.7%) 37 (33.3%)
Notes: *Patients may have undergone more than one type of limb surgery.
Abbreviations: ABI, ankle-brachial index; ACE, angiotensin converting enzyme; PAD, peripheral artery disease.Vascular Health and Risk Management 2010:6 291
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Figure 1 Model-based estimated survival curves for survival after bypass by age.
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Figure 2 Model-based estimated survival curves for survival after bypass by index ABI.
Abbreviation:   ABI, ankle-brachial index.
even larger increase in the hazard was observed for serum 
creatinines greater than 2.0 (HR 4.51; 95% CI: 2.00–10.17). 
Figures 4–7 present model-based estimated survival curves 
for survival after amputation bypass using smoking status, 
index ABI, history of CAD, and serum creatinine. Here 
again, in constructing the survival curve estimates for each 
figure, the other predictors were fixed at the most prevalent 
or median level.
Discussion
We identified age, disease severity, African American 
race, renal insufficiency at all levels (including a range of Vascular Health and Risk Management 2010:6 292
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Figure 3 Model-based estimated survival curves for survival after bypass by race/ethnicity.
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Figure 4 Model-based estimated survival curves for survival after amputation by smoking status.
normal serum creatinine to mild elevation), nonassessment 
of smoking status, and a history of coronary artery disease 
as risk factors associated with mortality following lower 
extremity bypass surgery and lower extremity amputation.
Advanced age is a known risk factor for PAD and other 
cardiovascular diseases.19,20 In addition, persons who are 
aged at least 65 years or older have an increased risk for 
mortality following both vascular and nonvascular surgery. 
We found that veterans aged 70 years and older were at an 
increased risk for mortality following lower extremity bypass 
surgery. As the proportion of US adults aged 70 years and 
older increases, efforts to optimize risk factor status prior to Vascular Health and Risk Management 2010:6 293
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Figure 5 Model-based estimated survival curves for survival after amputation by index ABI.
Abbreviation: ABI, ankle-brachial index.
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Figure 6 Model-based estimated survival curves for survival after amputation by CAD history.
Abbreviation: CAD, coronary artery disease.
elective surgeries such as lower extremity bypass surgery 
will also need to increase.
PAD severity is often defined by the ABI with lower 
levels indicating more severe disease. Prior studies have 
documented the association of the ABI with cardiovascular 
morbidity and mortality.7,21–23 The lower the ABI, the more 
severe the PAD, indicating more advanced atherosclerosis 
within the lower limb arterial beds. This more severe form of 
the disease is also a known marker for atherosclerosis in other 
vascular beds, most notably the coronary arteries, but also the 
carotid and intracerebral arteries. The more severe the PAD, 
the more limited the lower limb function with patients having Vascular Health and Risk Management 2010:6 294
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Figure 7 Model-based estimated survival curves for survival after amputation by serum creatinine.
leg discomfort with limited ambulation or even at rest.24,25 
Thus, the call for more aggressive surgical interventions in 
patients with severe PAD is not surprising. In our study, 
PAD severity was a marker for mortality following lower 
limb revascularization. This finding highlights the severity 
of co-existing atherosclerosis in vascular beds outside of 
the lower limbs and the necessity for continued aggressive 
atherosclerotic risk management.
Renal insufficiency is a known risk factor for coronary 
heart disease and stroke.26,27 Persons with renal insufficiency 
are also more likely to have coexisting and more severe 
PAD. In our prior work, renal insufficiency was shown to 
be a signficant risk factor for lower limb bypass surgery and 
lower limb amputation.10,28 For the present study, we highlight 
the association of renal insufficiency with increased mortal-
ity. Of note, even a serum creatinine in the range of normal 
to mild elevation was associated with an increased risk for 
mortality following lower extremity amputation. Reasons for 
our findings are not yet defined, but are likely multifactorial. 
Prior work has shown that even mild renal insufficiency is 
associated with increased cardiovascular mortality.29–31 These 
findings remain after adjustment for coexistent risk factors. 
We know that metabolic abnormalities are associated with 
impaired renal function and increase the risk for myocardial 
dysfunction and damage. Within our cohort, at least one-third 
of veterans with PAD had some degree of renal impairment 
while at least 50% of persons undergoing either lower limb 
bypass or lower limb amputation had some degree of renal 
impairment. The presence of renal impairment is likely 
an additional indicator of PAD severity and introduces 
additional unmeasured confounders within our study.
While not statistically significant, both current and non-
smokers had a lower risk for mortality following surgery as 
compared to persons whose smoking status was not assessed. 
Persons whose smoking status was not assessed were either 
not abstaining from smoking and possibly had a very high 
pack-year smoking history or had some other unmeasured 
variable that increased their risk for mortality. This lack of 
assessment reflects variability in physician documentation of 
smoking status and questions of reliability with patient self-
reports of smoking status. Clearly, an assessment of smoking 
status prior to surgery for PAD can lead to better optimization 
of this risk variable and improve long-term survival.
Our results are from a retrospective cohort study involving 
data abstraction from electronic and paper medical records. 
The data capture risk factor prevalence, disease severity, 
medication use, laboratory values, and physician documen-
tation of recommended care. Many of these variables are 
process-of-care measures. Each process measure captures 
a clinician’s efforts to treat a modifiable risk factor and a 
patient’s adherence to recommended therapy as well as an 
actual change in the risk factor of interest, and unmeasured 
confounding factors. Our smoking control variable is an 
excellent example of a process-of-care measure. The actual Vascular Health and Risk Management 2010:6 295
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variable reflects not only the frequency of physician 
documentation for this risk factor, but patient self-report of 
smoking cessation, and actual smoking cessation.
Admittedly, our study has some limitations. First, regard-
ing each process-of-care measure, we cannot tease apart 
which of the actual processes are presented in our findings. 
Second, given our retrospective cohort design, we are unable 
to evaluate other potentially important co-variables such as 
care obtained outside of the VA, medication adherence, and 
family support. Third, documentation bias is also a limitation 
given our use of paper charts and electronic medical records. 
In spite of the above limitations, our findings highlight that 
certain risk factors are associated with increased mortality 
following limb surgery for PAD.
Conclusion
In conclusion, PAD is a debilitating disease with an associ-
ated increased for sugical limb events and death. Our data 
provide information which surgeons can use to inform 
patients regarding risk for mortality following lower limb 
surgery for PAD.
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